Westpac Banking Corp’s 10x Genomics TXG Stock Holding History

Westpac Banking Corp’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-66,900	Closed	-$1.91M	–	792
2022 Q3	$1.91M	Buy	+66,900	New	+$2.55M	0.03%	512
2022 Q2	–	Sell	-5,456	Closed	-$415K	–	848
2022 Q1	$415K	Hold	5,456	–	–	﹤0.01%	791
2021 Q4	$813K	Buy	5,456 +426	+8%	+$65.3K	0.01%	723
2021 Q3	$732K	Hold	5,030	–	–	0.01%	763
2021 Q2	$985K	Hold	5,030	–	–	0.01%	756
2021 Q1	$910K	Hold	5,030	–	–	0.01%	708
2020 Q4	$712K	Buy	+5,030	New	+$730K	0.01%	781

Other funds holding TXG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SIM

SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Westpac Banking Corp's TXG Position: Q4 2022 in Review

Westpac Banking Corp sold out of 10x Genomics (TXG) in Q4 2022, closing a stake of 66,900 shares — an estimated $1.91M sold.

Westpac Banking Corp first reported a position in TXG in Q4 2020 and held it in 7 quarters. The position peaked at $1.91M in Q3 2022. 268 funds tracked by Wall St. Rank hold TXG as of Q4 2022.

Westpac Banking Corp reported no remaining 10x Genomics position as of Q4 2022 after selling out during the quarter.
Westpac Banking Corp sold 66,900 10x Genomics shares in Q4 2022, an estimated $1.91M.
Westpac Banking Corp first reported a position in 10x Genomics in Q4 2020 and held it in 7 quarters.
Westpac Banking Corp's 10x Genomics position peaked at $1.91M in Q3 2022.
268 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2022.

Based on Westpac Banking Corp's 13F filing for Q4 2022, filed 6 Feb 2023.